Related Experiment Videos
Stem cell factor: laboratory and clinical aspects
M A Smith1, E L Court, J G Smith
1Centre for Research in Biomedicine, Faculty of Applied Sciences, University of the West of England, Bristol, UK.
Blood Reviews
|January 17, 2002
Summary
Stem cell factor (SCF) promotes blood cell growth and survival. New inhibitors of SCF signaling offer potential treatments for Kit+ cancers like acute myeloblastic leukemia.
Area of Science:
- Hematology
- Molecular Biology
- Cancer Biology
Background:
- Stem cell factor (SCF) is a crucial growth factor for hematopoietic progenitor cells.
- SCF exhibits proliferative and anti-apoptotic functions, vital for blood cell development.
- SCF signaling pathways are increasingly understood by molecular biologists.
Purpose of the Study:
- To review recent advancements in Stem Cell Factor (SCF) signaling.
- To explore the therapeutic potential of SCF pathway inhibitors in Kit+ malignancies.
- To examine the synergistic roles of SCF in ex vivo cell expansion.
Main Methods:
- Literature review of the past five years.
- Analysis of molecular mechanisms of SCF signal transduction.
- Collating data on SCF inhibitors and their clinical implications.
Main Results:
- Dissection of SCF signaling pathways to the nucleus.
- Availability of novel molecules that inhibit SCF signaling.
- Demonstrated synergy of SCF with other cytokines for cell expansion.
Conclusions:
- SCF pathway inhibition presents a promising therapeutic strategy for Kit+ malignancies, including acute myeloblastic leukemia.
- Ex vivo expansion of hematopoietic progenitors and dendritic cells using SCF synergy holds therapeutic potential.
- Recent research highlights SCF's multifaceted roles in hematopoiesis and cancer therapy.